$0.450000
0.048.43%
Pre-Market: Feb 5, 8:06 AM EDT
15 minutes delayed
Comments
Loading...
Sio Gene Therapies Inc
SIOXOTC
Sio Gene Therapies Inc (OTC:SIOX) Stock, Analyst Ratings, Price Targets, Forecasts
Sio Gene Therapies Inc has a consensus price target of $0.9 based on the ratings of 3 analysts. The high is $1 issued by SVB Leerink on February 1, 2022. The low is $0.8 issued by Cantor Fitzgerald on April 28, 2022. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, HC Wainwright & Co., and SVB Leerink on April 28, 2022, February 1, 2022, and February 1, 2022, respectively. With an average price target of $2.93 between Cantor Fitzgerald, HC Wainwright & Co., and SVB Leerink, there's an implied 513.67% upside for Sio Gene Therapies Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
SVB Leerink
1calculated from analyst ratings
Analyst Ratings for Sio Gene Therapies Inc
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/28/2022 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | — | Downgrade | Buy → Sell | Get Alert |
| 04/28/2022 | Buy Now | 67.36% | Cantor Fitzgerald | Kristen Kluska | → $0.8 | Downgrade | Overweight → Neutral | Get Alert |
| 02/01/2022 | Buy Now | 1364.44% | HC Wainwright & Co. | Joseph Pantginis | $10 → $7 | Maintains | Buy | Get Alert |
| 02/01/2022 | Buy Now | 109.21% | SVB Leerink | Mani Foroohar | $6 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/21/2021 | Buy Now | 1992.05% | HC Wainwright & Co. | Joseph Pantginis | $8 → $10 | Maintains | Buy | Get Alert |
| 08/12/2021 | Buy Now | 1155.23% | SVB Leerink | Mani Foroohar | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Sio Gene Therapies Inc (SIOX) stock?
The latest price target for Sio Gene Therapies Inc (OTC:SIOX) was reported by HC Wainwright & Co. on April 28, 2022. The analyst firm set a price target for $0.00 expecting SIOX to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sio Gene Therapies Inc (SIOX)?
The latest analyst rating for Sio Gene Therapies Inc (OTC:SIOX) was provided by HC Wainwright & Co., and Sio Gene Therapies Inc downgraded their sell rating.
When was the last upgrade for Sio Gene Therapies Inc (SIOX)?
There is no last upgrade for Sio Gene Therapies Inc
When was the last downgrade for Sio Gene Therapies Inc (SIOX)?
The last downgrade for Sio Gene Therapies Inc happened on April 28, 2022 when HC Wainwright & Co. changed their price target from N/A to N/A for Sio Gene Therapies Inc.
When is the next analyst rating going to be posted or updated for Sio Gene Therapies Inc (SIOX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sio Gene Therapies Inc, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sio Gene Therapies Inc was filed on April 28, 2022 so you should expect the next rating to be made available sometime around April 28, 2023.
Is the Analyst Rating Sio Gene Therapies Inc (SIOX) correct?
While ratings are subjective and will change, the latest Sio Gene Therapies Inc (SIOX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Sio Gene Therapies Inc (SIOX) is trading at is $0.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.